Calyxt, Inc. – NASDAQ:CLXT
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
Calyxt stock price monthly change
+19.84%
month
Calyxt stock price quarterly change
+517.40%
quarter
Calyxt stock price yearly change
+8309.48%
year
Calyxt key metrics
Market Cap | 31.33M |
Enterprise value | 24.65M |
P/E | -0.88 |
EV/Sales | 157.03 |
EV/EBITDA | -1.61 |
Price/Sales | 92.59 |
Price/Book | 2.00 |
PEG ratio | N/A |
EPS | -3.33 |
Revenue | 756K |
EBITDA | -52.88M |
Income | -53.42M |
Revenue Q/Q | 1030.95% |
Revenue Y/Y | -63.26% |
Profit margin | -10758.6% |
Oper. margin | -14248.41% |
Gross margin | 100% |
EBIT margin | -14248.41% |
EBITDA margin | -6995.24% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCalyxt stock price history
Calyxt stock forecast
Calyxt financial statements
| Dec 2022 | 42K | -1.98M | -4721.43% |
|---|---|---|---|
| Mar 2023 | 42K | -6.32M | -15059.52% |
| Jun 2023 | 197K | -18.69M | -9487.31% |
| Sep 2023 | 475K | -26.42M | -5564% |
| Dec 2022 | 22421000 | 15.18M | 67.74% |
|---|---|---|---|
| Mar 2023 | 20285000 | 17.61M | 86.85% |
| Jun 2023 | 814268000 | 193.08M | 23.71% |
| Sep 2023 | 796235000 | 203.74M | 25.59% |
| Jun 2022 | -4.87M | -744K | -353K |
|---|---|---|---|
| Sep 2022 | -4.32M | -220K | -164K |
| Dec 2022 | -3.76M | -11K | 95K |
| Mar 2023 | -2.37M | 0 | 903K |
Calyxt alternative data
| Aug 2023 | 48 |
|---|---|
| Sep 2023 | 48 |
| Oct 2023 | 48 |
| Nov 2023 | 48 |
| Dec 2023 | 48 |
| Jan 2024 | 48 |
| Feb 2024 | 48 |
| Mar 2024 | 48 |
| Apr 2024 | 48 |
| May 2024 | 48 |
| Jun 2024 | 48 |
| Jul 2024 | 48 |
Calyxt other data
28.26%
+1.93%
of CLXT is owned by hedge funds
10.59M
+775.66K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 1000 | 0 |
| Dec 2023 | 517107 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | RIGGS RORY B director, 10 percent owner, off.. | Class A Common Stock | 517,107 | $10.58 | $5,470,992 | ||
Purchase | RIGGS RORY B director, 10 percent owner, off.. | Class A Common Stock | 1,000 | $31.5 | $31,500 | ||
Sale | RIBEILL YVES J director | Common Stock | 30,000 | $0.24 | $7,170 | ||
Sale | RIBEILL YVES J director | Common Stock | 20,000 | $1.06 | $21,240 | ||
Purchase | CARR MICHAEL A. director, officer: President an.. | Common Stock | 10,000 | $3.98 | $39,780 | ||
Purchase | KOSCHAK WILLIAM officer: Chief Fi.. | Common Stock | 20,000 | $3.21 | $64,120 | ||
Purchase | NEUGENT CHRISTOPHER J director | Common Stock | 15,000 | $3.95 | $59,295 | ||
Sale | VOYTAS DANIEL F officer: Chief Science Officer | Common Stock | 2,513 | $4.13 | $10,389 | ||
Sale | BLOME JAMES officer: Chief Executive Officer | Common Stock | 4,140 | $4.17 | $17,280 | ||
Sale | VOYTAS DANIEL F officer: Chief Science Officer | Common Stock | 5,026 | $4.75 | $23,874 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. William F. Koschak (1969) Chief Financial Officer | $481,460 |
| Dr. Travis J. Frey Ph.D. (1978) Chief Technology Officer | $426,760 |
-
When is Calyxt's next earnings date?
Unfortunately, Calyxt's (CLXT) next earnings date is currently unknown.
-
Does Calyxt pay dividends?
No, Calyxt does not pay dividends.
-
How much money does Calyxt make?
Calyxt has a market capitalization of 31.33M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 99.4% to 157K US dollars.
-
What is Calyxt's stock symbol?
Calyxt, Inc. is traded on the NASDAQ under the ticker symbol "CLXT".
-
What is Calyxt's primary industry?
Company operates in the Consumer Defensive sector and Packaged Foods industry.
-
How do i buy shares of Calyxt?
Shares of Calyxt can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Calyxt's key executives?
Calyxt's management team includes the following people:
- Mr. William F. Koschak Chief Financial Officer(age: 56, pay: $481,460)
- Dr. Travis J. Frey Ph.D. Chief Technology Officer(age: 47, pay: $426,760)
-
How many employees does Calyxt have?
As Jul 2024, Calyxt employs 48 workers.
-
When Calyxt went public?
Calyxt, Inc. is publicly traded company for more then 8 years since IPO on 20 Jul 2017.
-
What is Calyxt's official website?
The official website for Calyxt is calyxt.com.
-
Where are Calyxt's headquarters?
Calyxt is headquartered at 2800 Mount Ridge Road, Roseville, MN.
-
How can i contact Calyxt?
Calyxt's mailing address is 2800 Mount Ridge Road, Roseville, MN and company can be reached via phone at +65 16832807.
Calyxt company profile:
Calyxt, Inc.
calyxt.comExchange:
NASDAQ
Full time employees:
48
Industry:
Packaged Foods
Sector:
Consumer Defensive
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
2800 Mount Ridge Road
Roseville, MN 55113-1127
Roseville, MN 55113-1127
CIK: 0001705843
ISIN: US13173L1070
CUSIP: 13173L107
